Why the study?
Do various pharmacological agents attenuate the cardiostimulatory effects of ketamine in fit adults undergoing body surface operations?
Do various pharmacological agents attenuate the cardiostimulatory effects of ketamine in fit adults undergoing body surface operations?
Labetalol shows promise as an agent to attenuate the cardiostimulatory effects of ketamine during anesthesia induction.
Labetalol may blunt ketamine cardiostimulation in fit adults; hypothesis-generating and should not yet change practice.
In an attempt to attenuate the cardiostimulatory effects of ketamine, a number of drugs were given individually, or in combination, to fit adults undergoing body surface operations, either before or aftera ketamine induction of 1 mg kg-1 followed by an infusion of 1 mg ml-1. Of these, practolol, phentolamine, practolol-phentolamine, phentolamine-practolol, promethazine, hexamethonium, procainamide and verapamil were unacceptable. Labetalol, in doses of 0.5 mg kg-1 and 1.0 mg kg-1, proved to be the most promising drug and is worthy of further study.
No takes yet. Share an insight, caveat, or question.
LILBURN et al. (1978) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: